Clinical Trial 56974

Raleigh, NC 27601


Summary:

Diffuse Large B-Cell Lymphoma (DLBCL) At-Home Research Opportunity

At Sanguine, we are accelerating medicine with the help of volunteers like you. You can contribute to the development of new treatments and help advance Diffuse Large B-Cell Lymphoma (DLBCL) research with a 30 minute blood donation.

Donating is fast, easy, and you will receive up to $100 for your time without leaving home.

You may qualify to participate if you:

  • Are 18 to 85 years of age
  • Are diagnosed with Diffuse Large B-Cell Lymphoma (DLBCL)
  • Have not received R-CHOP within the past 30 days
  • Have not received any B-cell depleting therapies, such as, but not limited to rituximab, blinatumomab, or CD19-, CD20-, CD22-CAR T-cell therapy, in the past 30 days
  • Live in the United States


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.